Yellow Balloon Tour Co., Ltd. Logo

Yellow Balloon Tour Co., Ltd.

Offers domestic & international travel packages, flights, and tours for individuals and groups.

104620 | KO

Overview

Corporate Details

ISIN(s):
KR7104620000
LEI:
Country:
South Korea
Address:
서울특별시 중구 수표로 31 (저동2가, 노랑풍선빌딩), 중구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Yellow Balloon Tour Co., Ltd. is a travel agency established in 2001 that provides a comprehensive range of domestic and international travel services. The company offers a variety of travel products, including overseas package tours, domestic trips, and specialized theme-based travel such as honeymoon, golf, and cruise packages. In addition to full packages, it provides individual travel components like flights, hotels, tours, tickets, KTX rail passes, and rental cars. The company caters to individual travelers, corporate clients, and group tours. A notable service is the operation of the Yellow Balloon City Bus for tours within Seoul. It focuses on tourism product development and travel arrangement services for both outbound and inbound travelers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 63.0 KB
2025-09-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 63.0 KB
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 63.0 KB
2025-09-01 00:00
Share Issue/Capital Change
전환가액의조정 (제3회차)
Korean 10.5 KB
2025-09-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 61.8 KB
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 61.8 KB
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 62.0 KB
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 62.9 KB
2025-08-29 00:00
Share Issue/Capital Change
전환청구권행사 (제3회차)
Korean 10.3 KB
2025-08-21 00:00
Share Issue/Capital Change
전환청구권행사 (제3회차)
Korean 9.8 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-12 00:00
Share Issue/Capital Change
전환청구권행사 (제3회차)
Korean 9.4 KB
2025-08-07 00:00
Share Issue/Capital Change
전환청구권행사 (제3회차)
Korean 9.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.2 MB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.7 KB

Automate Your Workflow. Get a real-time feed of all Yellow Balloon Tour Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Yellow Balloon Tour Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Yellow Balloon Tour Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel
NRGN
Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060

Talk to a Data Expert

Have a question? We'll get back to you promptly.